Cargando…
Microbiota Influences Vaccine and Mucosal Adjuvant Efficacy
A symbiotic relationship between humans and the microbiota is critical for the maintenance of our health, including development of the immune system, enhancement of the epithelial barrier, and acquisition of nutrients. Recent research has shown that the microbiota impacts immune cell development and...
Autor principal: | Kim, Yun-Gi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334119/ https://www.ncbi.nlm.nih.gov/pubmed/28261017 http://dx.doi.org/10.4110/in.2017.17.1.20 |
Ejemplares similares
-
Mucosal vaccine adjuvants update
por: Rhee, Joon Haeng, et al.
Publicado: (2012) -
Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022) -
Understanding Host Immunity and the Gut Microbiota Inspires the New Development of Vaccines and Adjuvants
por: Yakabe, Kyosuke, et al.
Publicado: (2021) -
Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin
por: Kim, Donghyun, et al.
Publicado: (2016) -
Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines
por: Savelkoul, Huub F. J., et al.
Publicado: (2015)